Vivo Opportunity Fund Holdings, L.P. 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 08:30 am Unchanged |
2025-03-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Vivo Opportunity Fund Holdings, L.P. | 6,096,173 9.990% |
0 (Unchanged) |
Filing |
| 2024-11-14 7:01 pm Purchase |
2024-10-09 | 13G | Unicycive Therapeutics, Inc. UNCY |
Vivo Opportunity Fund Holdings, L.P. | 6,096,173 9.990% |
100,000 (+1.67%) |
Filing |
| 2023-07-14 4:30 pm Purchase |
2023-07-11 | 13G | Unicycive Therapeutics, Inc. UNCY |
Vivo Opportunity Fund Holdings, L.P. | 5,996,173 9.990% |
5,996,173 (New Position) |
Filing |